Presence of circulating tumor cells in high-risk early breast cancer during follow-up and prognosis

AbstractBackground. The prognostic relevance of circulating tumor cells (CTCs) at the time of primary diagnosis has been well established. However, little info

Saved in:
Bibliographic Details
Main Authors: Trapp, Elisabeth (Author) , Schneeweiss, Andreas (Author)
Format: Article (Journal)
Language:English
Published: 2019
In: Journal of the National Cancer Institute
Year: 2018, Volume: 111, Issue: 4, Pages: 380-387
ISSN:1460-2105
DOI:10.1093/jnci/djy152
Online Access:Verlag, Volltext: https://doi.org/10.1093/jnci/djy152
Verlag, Volltext: https://academic.oup.com/jnci/article/111/4/380/5127124
Get full text
Author Notes:Elisabeth Trapp, Wolfgang Janni, Christian Schindlbeck, Julia Jückstock, Ulrich Andergassen, Amelie de Gregorio, Marianna Alunni-Fabbroni, Marie Tzschaschel, Arkadius Polasik, Julian G. Koch, Thomas W.P. Friedl, Peter A. Fasching, Lothar Haeberle, Tanja Fehm, Andreas Schneeweiss, Matthias W. Beckmann, Klaus Pantel, Volkmar Mueller, Brigitte Rack, Christoph Scholz; on behalf of the SUCCESS Study Group
Description
Summary:AbstractBackground. The prognostic relevance of circulating tumor cells (CTCs) at the time of primary diagnosis has been well established. However, little info
Item Description:Published online: October 11, 2018
Gesehen am 14.05.2019
Physical Description:Online Resource
ISSN:1460-2105
DOI:10.1093/jnci/djy152